EHVVF — ehave Share News
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
- $0.74m
- -$1.01m
- $0.00m
Brief: AIbotics Signs Agreement To Develop UI/UX For Phill Robot, Its AI-Powered Massage Robot
Brief: FDA Consents Ehave To Proceed Its Clinical Study On Intravenous Ketamine Infusion
Brief: Ehave Says Mycotopia Therapies Agrees On Triangular Merger With Ei.Ventures to Form PSLY.com to List on NASDAQ
Brief: Ehave Plans Stock Distribution Mycotopia Therapies Plans To Merge With Ei. Ventures
Brief: Former member of National Advisory Council on Drug Abuse and National Institute on Drug Abuse Joins Ehave Inc
Brief: Ehave, Inc. Files To List On The Canadian Stock Exchange And Applies To Upgrade To Otcqb Exchange
Brief: Ehave Inc Announces Repositioning Of Mycotopia Therapies To Maximize Shareholder Value
Brief: Ehave Signs Licensing Agreement To Enhance Its Telemedicine Platform
Brief: Ehave To Acquire Mdlink
Brief: Ehave To Explore Strategic Alternatives
Brief: Aequus And Ehave Enter Into Collaboration Agreement
Brief: Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement
Brief: Ehave, Aequus enters into a collaboration
Brief: Ehave appoints Dave Goyette as chief technology officer